Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07855679 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pulmonary Embolism Registry From Short-Term Emergency to Long-Term Follow-Up and Surveillance

Study acronym: PERSEUS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 2 of 2 changed
See other at-risk trials from Azienda Ospedaliero-Universitaria Careggi

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Secondary endpoints: details revised at 3 of 8 entries
    • Publications: 2 to 8
  2. Notable Primary endpoint(s) modified Show 8 more changesShow less
    • Start date pushed from Jan 1, 2023 to Jun 19, 2026
    • Trial sites expanded: 9 → 16 locations
    • Interventions modified
    • Secondary endpoints: 5 to 8
    • Study description expanded, about 42 words
    • Collaborators revised (9)
    • Eligibility criteria shortened, about 3 words
    • Study title expanded, about 1 word
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
PERSEUS is an academic, investigator-initiated, multicenter observational registry of adults with acute pulmonary embolism (PE), promoted by Azienda Ospedaliero-Universitaria Careggi (Florence, Italy). It collects data generated during routine care across the whole course of the disease: pre-hospital care when available, emergency department presentation, the hospital stay (including bedside reassessments in the first 48 hours when performed as part of care) and follow-up up to 5 years. The registry has a retrospective cohort (patients diagnosed from 1 January 2023 until local ethics committee approval, with data taken from medical records) and a prospective cohort (consecutive patients enrolled after approval). Taking part in the registry does not change patient care: all tests and treatments are decided by the treating physicians. The registry aims to describe how acute PE is managed in everyday practice and how often patients die (from any cause and from PE), deteriorate hemodynamically, have recurrent venous thromboembolism or bleeding, and develop long-term complications such as chronic thromboembolic pulmonary hypertension. The database also supports ancillary analyses with separate pre-specified analysis plans, such as the evaluation of existing risk-stratification tools.
Trial Details
NCT Number NCT07855679
Lead Sponsor Azienda Ospedaliero-Universitaria Careggi
Collaborators: University of Florence, Azienda USL Toscana Centro, Azienda Ospedaliera di Perugia, Cardarelli Hospital, Naples, Italy, Azienda Ospedaliero, Universitaria Pisana, Azienda USL Toscana Nord Ovest, Medical University of Warsaw, Hospital Universitario Ramon y Cajal, A.O.U. Città della Salute e della Scienza - Molinette Hospital
Conditions
(from sponsor)
Venous Thromboembolism (VTE), Chronic Thromboembolic Pulmonary Hypertension, Right Ventricular Dysfunction, Pulmonary Embolism (PE)
Related terms Emergencies, Heart Arrest, Pulmonary Embolism, Venous Thromboembolism, Ventricular Dysfunction, Right
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov